Respiratory

New data confirm that positive airway pressure therapy is associated with a significant reduction in all-cause and cardiovascular mortality in patients with obstructive sleep apnoea.

New research finds that SGLT-2is and GLP-1RAs are associated with a lower risk of COPD exacerbations in patients with Type 2 diabetes and active COPD.

New research has identified a potential causal relationship between lipid metabolism and chronic obstructive pulmonary disease.

Adjuvant corticosteroid therapy reduces 30-day mortality in hospitalised patients with community-acquired pneumonia, but its benefits depend on baseline inflammation levels.

Gut microbiota composition may influence the efficacy and safety of chemo-immunotherapy in advanced non-small cell lung cancer.

A Phase IV trial has demonstrated that dupilumab significantly reduces airway inflammation in patients with uncontrolled, moderate-to-severe type 2 asthma.

Interim findings from the ongoing SOTERIA study suggest that sotatercept provides a favourable long-term safety and efficacy profile for adults with pulmonary arterial hypertension.

A new study assessed asthma risk in children who received antibiotics in the first week of life solely due to maternal indications, eliminating infection-related bias.